AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Villars Holding S.A.

Annual / Quarterly Financial Statement Oct 1, 2015

1008_10-k_2015-10-01_5339fe35-cd96-4ea5-bcad-2f3fcf0eb667.pdf

Annual / Quarterly Financial Statement

Open in Viewer

Opens in native device viewer

AXON HOLDINGS S.A.

SHORT FORM FINANCIAL DATA AND INFORMATION FOR THE YEAR 1/1-31/12/2007

(published in accordance with L. 2190, article 135, regarding companies preparing annual financial statements, consolidated or not, in accordance with the I.F.R.S.) The following data and information aim at providing view of the financial position and the results of the Group and the company AXON HOLDINGS S.A. Interested parties who seek to obtain a full account of the Company's finan Independent Auditor. Indicatively, they can access the company's web site, www.axonholdings.gr, where the aforementioned infomation is posted.

Company Registered Offices:
Foundation Date:
INCOME STATEMENT
(All amounts in thousands of Euro €)
04/12/1987 G.N 2957/23.12.87
Main Activity:
Holdings Company
16226/06/B/87/17
S.A. Registration No:
GROUP
1/1-31/12/07
1/1-31/12/06
COMPANY
1/1-31/12/07 1/1-31/12/06
Supervising Authority:
and Credit
Ministry of Development, Administration of S.A.'s Sales
Gross profit
222.085
54.439
201.895
61.542
n
0
n
0
Members of the Board of Directors:
Terzopoulos Apostolos (President), Doumanoglou
Panagiotis (Managing Director), Nanopoulos
Profits before taxes, financing results, investment
results and depreciation
34.984 48.495 705 1.844
Dimitrios (Member), Nikolaidis Petros (Member)
Paka Paraskeui (Member)
Approval date of the Financial Statements (out of
Profit before taxes, financing and ivnestment results
Results before income taxes
23.139
33.220
38.665
31.151
703
6.589
1.843
2.133
which the brief financial statements were drawn):
Independent Auditor:
26 March 2008 Koutras Grigorios, SOEL R.N. 13601 Minus Income taxes
Results after income taxes from continued
(15.017) (15.384) (1.429) (3.834)
Auditing Firm:
Audit Report Type:
BDO PROTYPOS HELLENIC AUDITING Co S.A. Unqualified opinion - matters of emphasis operations (a)
Results after income taxes from discontinued
18.203 15.767 5.160 (1.701)
www.axonholding.gr
Company web site:
operations (b)
Results after income taxes form continued and
0 0 0 0
BALANCE SHEET as of 31st December 2007
(All amounts in thousands of Euro $\epsilon$ )
discontinued operations) $(a) + (b)$
Attributable to:
18.203 15.767 5.160 (1.701)
ASSETS GROUP
31/12/2007 31/12/2006
COMPANY
31/12/2007 31/12/2006
Company shareholders
Minority shareholders
5.956
12.247
3.294
12.473
5.160
0
(1.701)
$\Omega$
Tangible assets & Intangible assets
Inventories
490.791
25.650
325.835
27.223
165.358
1.118
85.720
0
Earnings after taxes per share (in Euro) 0,20 0,12 0,16 (0.05)
Trade receivables
Other Assets
96.205
197.720
83.832
85.707
0
3.333
0
3.701
CASH FLOW STATEMENT
(All amounts in thousands of Euro €)
TOTAL ASSETS
EQUITY AND LIABILITIES
810.366 522.598 169.809 89.422 1/1-31/12/07 GROUP COMPANY
1/1-31/12/07 1/1-31/12/06
Non-Current Liabilities
Current Bank Liabilities
172.563
148.366
79.572
86.987
14.064
33.730
1.189
16.086
Cash flows from operating activies:
Profit before income taxes
33.220 1/1-31/12/06
31.151
6.589 2.133
Other Current Liabilities
Total Liabilities (a)
230.843
551.772
214.785
381.344
18.028
65.821
8.416
25.691
Plus (minus) adjustements for:
Depreciation and amortisation expenses
11.845 9.830 3 -1
Share Capital
Other items of Shareholders' Equity
24.712
100.427
19.222
33.848
24.712
79.276
19.222
44.509
Provisions
Loss / (gain) on disposal of fixed assets
1.831
1.675
2.452
(1.048)
(839)
n
(1.880)
0
Total Equity attributable to Share holders (b)
Minority Interests (c)
125.139
133.456
53.070
88.184
103.988
n
63.731
0
Loss / (gain) on investments
Income from depreciation of fixed assets grants
(19.098)
(286)
(837)
(29)
(4.961)
n
(236)
0
Total Equity $(d) = (b) + (c)$
TOTAL EQUITY AND LIABILITIES (a) + (d)
258.594
810.366
141.254
522.598
103.988
169.809
63.731
89.422
Income from participations
Loss / (gain) from participating interests
(38)
227
(19)
4
(2.765)
n
(980)
0
STATEMENT OF CHANGES IN EQUITY Debit interest and other related expenses 12.165
41.540
7.746
49.249
1.346
(626)
925
(36)
(All amounts in thousands of Euro €) GROUP COMPANY Plus / (minus) adjustments for changes in working capital
Equity at the beginning of the year 1/1-31/12/07 1/1-31/12/06 1/1-31/12/07 1/1-31/12/06 or operatiing activities accounts:
Decrease / (Increase) in Inventories
1.717 (9.536) $\mathbf{0}$ 0
(01/01/2007 and 01/01/2006)
Results after income taxes
141.254
18.203
126.586
15.767
63.731
5.160
65.747
(1.701)
Decrease / (Increase) in receivables
Decrease / (Increase) in Non-Current receivables
(Decrease) / Increase in liabilities (except bank loans)
(46.891)
1.357
53.786
(16.724)
1.784
3.350
4.083
(6)
468
(383)
0
2.212
Increase in share capital
Dividends
35.960
(6.860)
0
(1.706)
35.960
0
0
(315)
(Minus):
Net income directly attributable in equity
(Purchases) / Sales of treasury shares
59.305
10.732
663
(56)
0
(863)
0
0
Debit interest and other related expenses paid
Income taxes paid
(13.725)
(9.130)
(8.241)
(6.986)
(1.346)
(1.429)
(925)
(925)
Other adjustments
Equity at the end of the period (31/12/2007
0 0 0 0 Total Cash flows from operating activities (a)
Cash Flows from Investing Activities:
28.654 12.896 1.144 (57)
and 31/12/2006) 258.594 141.254 103.988 63.731 Acquisition of subsidiaries, associates, joint ventures and
other investments
(119.576) (8.285) (24.861) (197)
ADDITIONAL DATA AND INFORMATION Purchase of treasury shares
Purchase of tangible and intangible assets
(863)
(35.710)
(12)
(22.908)
(863)
(5)
0
$[4]$
1. The companies included in the consolidated financial statements of the closing year are the following.
A. Total consolidation method
Country Participating Unaudited Proceeds from tangible and intangible assets sales
Proceeds from financial assets and investments sales
6.585
32.387
1.511
3.082
n
8.291
0
302
AXON HOLDINGS S.A. Hellas interest
parent company
Years
2005-2007
Proceeds from financial assets
Interest received
837
723
490 n 0
0
EUROMEDICA S.A.
HELLENIC OPTHALMOLOGICAL CENTER ORASIS S.A.
Hellas
Hellas
57,10%
40,54%
2006-2007
2007
Proceeds from grants for investements in fixed assets
Dividends received
926
n
n
19
n
2.278
0
689
IPPOKRATIS CENTER OF NUCLEAR MEDICINE S.A.
MEDICAL DIAGNOSTIC CENTER VOLOS «YGEIA VOLOU» S.A.
Hellas
Hellas
34,26%
29,12%
2005-2007
2004-2007
Total Cash Flows from Investing Activities (b) (114.692) (26.098) (15.160) 790
MELAMBUS MEDICINE S.A.
OBSTETRIC GYNECOLOGICAL CLINIC «THEOTOKOS» S.A.
Hellas
Hellas
42,40%
40,35%
2007
2007
Cash Flows from Financing Activites:
Proceeds from share capital increase
0 0 0 0
EUROMEDICA MULTIDIAGNOSTIC CENTER LARISA S.A.
PRIVATE DIAGNOSTIC CENTER PYLI AKSIOU S.A.
Hellas
Hellas
39,97%
42,42%
2007
2003-2007
Proceeds (repayments) of loans
Payments of leases liabilities
104.708
7.516
22.624
(3.686)
14.829
n
(317)
0
OBSTETRIC GYNECOLOGICAL CLINIC THESSALONIKI «GENESIS» S.A.
EUROMEDICA AROGI MEDICAL CENTER APOKATASTASI S.A.
Hellas
Hellas
28,55%
51,39%
2007
2003-2007
Dividends paid
Board of Directors' fees
(8.242)
(386)
(1.845)
(531)
(662) (459)
GENERAL CLINIC OF DODEKANISA S.A.
EURO PROCUREMENT S.A.
Hellas
Hellas
32,77%
57,02%
2003-2007
2007
Total Cash Flows from Financing Activities (c)
Net increase / (decrease) in cash and cash
103.596 16.562 14.167 (777)
SONAK S.A.
AXON SECURITIES
Hellas
Hellas
52,51%
40,00%
2005-2007
2005-2007
equivalents $(a)+(b)+(c)$
Cash and cash equivalents at the beginning of year
17.559
13.146
3.360
9.785
151
73
(44)
117
ELSON S.A.
DATA DESIGN S.A.
Hellas
Hellas
52,51%
45,62%
2003-2007
2003-2007
Cash and cash equivalents of merged companies
Cash and cash equivalents at the end of year
139
30.843
n
13.146
139
363
0
73
PRISMA TECHNICS S.A.
NEOS EGEFALOS S.A.
Hellas
Hellas
27,68%
62,35%
2005-2007
2003-2007
people respectively.
MAGNETIC TOMOGRAPHY VOLOS S.A.
SERRES AXONIKOS TOMOGRAPHOS S.A.
Hellas
Hellas
18,56%
26,84%
2003-2007
2003-2007
7. Investments in fixed assets during the current period came up to: € 5 k. for the Company and € 35.710 k. for the Group.
8. At 31 December 2007 the decision numbered K2-17814/21-12-2007 was approved by the Ministry of Development regarding the
PROLIPTIKI IATRIKI P. FALIROU L.T.D.
YGEIA MAGNETIC DIAGNOSI PTOLEMAIDA S.A.
Hellas
Hellas
27,94%
27,98%
2006-2007
2003-2007
break up contract plan of the company ACHAIKI INDUSTRY OF ADVANCED TECHNOLOGY S.A. with S.A. registration no
42412/22/B/99/23, according to which, the branch "Production of advanced technology products and services, buildings, lands and
technical projects" of the company is broken up and absobed by the parent company of the Group AXON HOLDINGS S.A. and the
EUROMEDICA FINANCE No 1 S.A.
TOURISTIC ENTERPRISES W. MACEDONIA S.A.
Luxembourg
Hellas
57,10%
51,39%
2007
2003-2007
Investments' branch by the associated company of the Group MYSTRAS S.A. INVESTMENTS AND BUSINESS PARTICIPATION
according to the decision of the General Meeting of the shareholders dated 8/12/07, according to the provisions of articles 81-85 of
EGEFALOS PELOPONNISOU S.A.
«ARISTOTELEIO» PRIVATE DIAGNOSTIC LABORATORY
Hellas 100% 2003-2007 [CL 2190/1920 and the articles 1-5 of the L. 2166/1993 (see Note 7 to the annual financial statements).
9. A share capital increase was decided by the Extraordinary General Meeting of the Group's Subsidiary Company EUROMEDICA S.A.
AXONIKOS TOMOGRAPHOS MEDICAL S.A.
AXIAL AND DIAGNOSTIC KORINTHOS S.A.
Hellas
Hellas
29,78%
23,42%
2003-2007
2004-2007
shareholders on 30/6/2007, by issuing 7.500.000 new common shares, of nominal value 1,55 € each, in cash and by partial
cancellation of the old shareholders preemptive right. The new shares were offered in favour of the company HEALTHCARE
MEDINET ALEXANDROUPOLI S.A.
AROGI S.A.
APOKASTASI S.A.
Hellas
Hellas
Hellas
27,98%
28,55%
28,55%
2003-2007
2006-2007
2006-2007
INVESTORS (GREECE) L.L.C. and the company AXON HOLDINS S.A. The issue price of the new shares was 8,00 € per share. The
aforementioned share capital increase of the Company was approved by the decision numbered K2-1628/11-7-2007 of teh Ministry
EUROMEDICA ANATOLIKI ATTIKI PRIVATE MULDIMEDICAL CENTER S.A.
IONIOS GENERAL CLINIC S.A. UTILISATION AND FUCTION OPERATOR
Hellas 41,00% 2007 of Development and after the fulfillmen of the share capital increase procedure, the new shares were listed in the Athens Stock
Exchange on 28/8/2007, and they are entitled to receive dividend from the profits of the year 2007.
QUARANTINE ABSTRACTION S.A. (CORFU)
IATRIKI MEGARON PRIVATE DIAGNOSTIC LABORATORY S.A.
Hellas
Hellas
28,55%
42,83%
2004-2007
2006-2007
10. The Boards of Directors of the parent company of the Group EUROMEDICA S.A. and its subsidiary companies GENERAL CLINIC
OF THESSALONIKI S.A., MEDICAL CENTER OF ADVANCED TECHNOLOGY KRITI S.A. and MEDICAL INSTITUTE OF ADVANCED
IONIA PRIVATE POLYIATRIO IATRIKI S.A.
IONIA NEFROLOGIKI UNIT OF CHRONIC HEMODIALYSIS S.A.
Hellas
Hellas
51,39%
27,98%
2006-2007
2006-2007
TECHNOLOGY WEST MACEDONIA S.A. decided, at 28/9/2007, the merger by absorption of th given three subsidiaries by the parent
companny EUROMEDICA S.A The 30th of September 2007 was appointed as transformation date and the merger was
accomplished according to the provisions of L. 2166/1993 and of C.L. 2190/1920. The aforementioned merger was approved by the
GALINOS MEDICAL DIAGNOSTIC TRIKALON S.A.
MULTIDIAGNOSTIC CENTER OF PIERIA S.A.
Hellas
Hellas
25,70%
38,18%
2005-2007
2003-2007
decision numberd K2-18601/31-12-2007 of the Ministry of Development (see Note 8 to the annual financial statements).
11. The cumulative amounts of sales and purchases from the opening of the fiscal year and the balances of claims and liabilities of
B. Equity Method
EUROGENETIC S.A. PROTYPOS CENTRE OF RESEARCH AND APPLICATION
the Group and the Company to the end of the current year, regarding from transactions with related parties, as dictated by IAS 24,
are as follows (amounts in thousands of euro $\epsilon$ ):
OF MOLECULAR BIOLOGY
MEDITRON S.A.
Hellas
Hellas
22,84%
22,81%
2006-2007
2003-2007
a) Sales of goods and services GROUP
529
COMPANY
359
DORMED HELLAS S.A.
N. IONIA AXIAL TOMOGRAPHY S.A.
Hellas
Hellas
19,96%
22,84%
2003-2007
2004-2007
b) Purchases of goods and services
c) Receivables
2.144
35.117
25
7.837
MEDECINE DIAGNOSTIC LABORATORY KOZANI MEDICINE S.A.
PRIVATE POLYIATRIO IATRIKI S.A. (MEDICINE DIAGNOSIS OF LESVOS S.A.)
Hellas
Hellas
11,99%
19,99%
2007
2007
d) Liabilities
e) Transaction and fees of management executives and administration members
11.447
3.470
11.301
0
MEDINET KAVALAS PRIVATE DIAGNOSTIC CENTER S.A.
2. The matters of emphasis which the independent Auditor is referred to in the Audit Report, concern: a) pending law suits, b)
Hellas 19,42% 2003-2007 f) Receivables from managerial executives and administration members
g) Liabilities to management executives and administration members
0
0
n
0
unaudited years by tax authorities.
3. At 1/1/2007, the Group's Management decided to change the accounting policy of the privately owned property (land and
buildings) from that of historical cost to revaluation in the fair value in frequent time intervals. The emerging goodwill fo the Group
amounted to € 48.496 k. resulting in the increase of the Group's and the Company's equity by the amount of € 36,37 k. (from which
e 17.807 k. was attributable to minority shareholdes), after the deduction of the deferred tax liability amounting to € 12.124 k. (see LABORATORY S.A., IONIA PRIVATE POLYIATRIO IATRIKI S.A., IONIA NEFROLOGIKI UNIT OF CHRO
Note 9 to the annual financial statements).
4. Prenotes on the property and land of the Company and the Group of total amount $\epsilon$ 14,3 mil. $\kappa$ at $\epsilon$ 94,4 mil. respectively have
been recorded as loan quarantees.
5. There are raised law suits against companies of the Group claiming in total $\epsilon$ 49,6 mil., the biggest part of whom is covered by
special insurance contracts. Furthemore, a legal recourse has been taken by a subsidiary company for unresolved tax differences
concerning an amount of $\epsilon$ 11,5 mil approximately. It is estimated that the lawsuits will have no material effect on the economic
position of the Group.
12. In the consolidated financial statements of the current year are included for the first time the financial statements of the
companies: YGEIA MAGNETIC DIAGNOSI S.A., TOURISTIC ENTERPRISES W. MACEDONIA S.A., PRIVATE DIAGNOSTIC LABORATORY
ARISTOTELEIO AXIAL TOMOGRAPHY MEDICAL S.A. and EUROMEDICA FINANCE No 1 S.A., DATA DESIGN S.A., AXIAL AND
DIAGNOSTIC KORINTHOS S.A., MEDINET ALEXANDROUPOLI S.A., AROGI S.A., APOKATASTASI S.A., EUROMEDICA ANATOLIKI
ATTIKI PRIVATE MULTIMEDICAL CENTER S.A., IONIOS GENERAL CLINIC S.A. (CORFU), IATRIKI MEGARON PRIVATE DIAGNOSTIC
GALINOS MEDICAL DIAGNOSTIC TRIKALON S.A., and MULTIDAIGNOSTIC CENTER OF PIERIAS S.A. which were included for the first
time with the consolidated method beginning from 1/1/2007, 1/4/2007, 1/4/2007, 30/6/2007, 1/9/2007, 30/9/2007, 1/9/2007,
1/9/2007, 1/7/2007, 31/12/2007, 6/12/2007, 1/10/2007, 1/10/2007, 1/10/2007, 23/11/2007, and 1/11/2007 respectively.
Addiitionally, the associated companies EUROGENETIKI S.A., MEDITRON S.A., DORMED HELLAS S.A., N. IONIA AXIAL
TOMOGRAPHY S.A., MEDECINE DIAGNOSTIC LABORATORY KOZANI MEDICINE S.A., PRIVATE POLYIATRIO IATRIKI S.A. (MEDICINE
DIAGNOSIS OF LESVOS S.A.) and MEDINET KAVALAS PRIVATE DIAGNOSTIC CENTER S.A. which were consolidated for the first time
with the equity method beginning from 1/11/2006, 31/12/2006, 1/6/2007, 30/6/2007, 1/10/2007, 1/11/2007 and 31/12/2007
6. The number of personnel of the Company and the Group at the end of the current year was 14 (2006: 4) and 2.269 (2006: 1.899)
respectively.
Athens, March 26, 2008
The Chief Executive Director
TERZOPOULOS APOSTOLOS
The Managing Director
DOUMANOGLOU PANAGIOTIS
Head of Accounting Department
LIAKOS LOUKAS
ID. No S 636315/98 ID. No. S 2322215/00 ID. No. T 017003

Talk to a Data Expert

Have a question? We'll get back to you promptly.